Stocks · Health care · Pharmaceutical Preparations

Cartesian Therapeutics, Inc.

RNAC Clue Score28
United States Fiscal year ends December CIK 0001453687 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Blaine Davis
6 Jan 2026
Chief Financial Officer
Sell
10,591
$6.82
$72.23K
Milos Miljkovic
6 Jan 2026
Chief Medical Officer
Sell
3,573
$6.82
$24.37K
Carsten Brunn
6 Jan 2026
President and CEO
Sell
23,766
$6.82
$162.08K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 1,819,257
History held since 23 Jun 2016